MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Canadian Federal Government has confirmed it will move to legalise the recreational cannabis market by 1 July 2018. The Federal Government's initial plans and proposed legislative framework are expected to be publically released on 10 April 2017.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, HL Pharma Pty Ltd, has received approval for a medicinal cannabis importation licence from the Department of Health.
(NetworkNewsWire) The human body is elegantly designed to heal itself, utilizing the immune system as its defense against various pathogens. Triggered by immune response signals, the immune system attacks and kills organisms and substances that invade body systems and cause disease. However, the immune system sometimes needs help in identifying and killing some invaders.
An oral drench to protect piglets from gut infection could soon be available to pig farmers. It's been developed by scientists and is made from pineapples - taking antibiotics out of the food chain.
(NetworkNewsWire) TapImmune, Inc. (NASDAQ:TPIV) is leading the field of oncology with its next-generation T-cell vaccines and novel immunotherapy platforms. By fully leveraging the scope of its technology and through collaborative partnerships and license agreements, the company aims to maximize its value and growth potential.
Stemcell United Ltd (ASX:SCU) is pleased to announce the appointment of Medicinal Cannabis expert Mr. Nevil Schoenmakers as a Strategic Advisor to the Board to assist the Company assess opportunities in the medicinal cannabis sector.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the following sales and operations update on its wholly-owned Switzerland-based subsidiary, Satipharm AG.
